Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate-to-severe reductions in renal function.

摘要: This study compared the use of antihypertensive treatment and blood pressure (BP) controls between patients with diabetic kidney disease (DK+) non‐diabetic (DK−) exhibiting moderate‐to‐severe chronic renal failure who did not need replacement therapy. A cross‐sectional survey included all s‐creatinine at ⩾200 µmol/l attending regular control sessions six units in Norway. Of 351 included, 73 (20.8%) were DK+. The proportion reaching a BP goal <130/80 mmHg was similar DK+ DK− (14.1% vs 13.6%, p = 0.92), while 38% 39% achieved <140/90 mmHg, respectively. systolic more difficult to achieve than diastolic (35% 15%) despite mean three different types drugs being used. Loop diuretics beta‐adrenergic‐receptor antagonists most frequently prescribed drugs, angiotensin‐converting enzyme inhibitors or angiotensin‐II‐receptor antagonis...